Gls Pharma Limited - Company Profile

It is a pharma public limited company based in Seri Lingampally, Telangana, India, established in 2004.
2004 Seri Lingampally, Telangana, India Active
Last Updated:
Access Report
About Gls Pharma Limited

Gls Pharma Limited, a active public limited company, was established on 01 September 2004 in Seri Lingampally, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TS2004PLC184306. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.30 Cr and a paid-up capital of ₹1.20 Cr.

Formerly known as Gls Pharma Private Limited, Getwell Life Sciences India Private Limited.. It upholds a compliant status. Employing 116 professional, Its leadership includes Srinivasa Ramachandra Rao Ilapakurthy (Director), Pendem Harish Babu (Additional Director), Ravikiran Namburi (Director). Past directors included Sanjay Koganti, Surbhi Pathak, Sanjeev Indravadan Dani. It holds ₹2.00 Cr open charges and ₹15.83 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1,, Hyderabad Knowledge City, Raidurg Panmaktha,, Seri Lingampally, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TS2004PLC184306

  • Registration Number

    184306

  • Incorporation Date

    01 September 2004

  • Authorized Capital

    ₹1.30 Cr

  • Paid-Up Capital

    ₹1.20 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.30 Cr
  • Paid Up Capital ₹ 1.20 Cr
  • Company Age 21 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.00 Cr
  • Satisfied Charges ₹ 15.83 Cr
  • Revenue Growth **** 13862.30%
  • Profit Growth **** 8628.69%
  • Ebitda **** 12459.10%
  • Net Worth 22564.11%
  • Total Assets **** 18288.93%
Company report

Gls Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gls Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Gls Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Srinivasa Ramachandra Rao Ilapakurthy Director 15 Dec 2023 Current
Pendem Harish Babu Additional Director 25 Oct 2025 Current
Ravikiran Namburi Director 20 Sep 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 22 Mar 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 26 Aug 2019 Past
Pramod Abcsdd Additional Director 12 Aug 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gls Pharma.

Gls Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13862.3% increase. The company also saw a substantial improvement in profitability, with a 8628.69% increase in profit. The company's net worth Soared by an impressive increase of 22564.11%.

Gls Pharma revenue growth over time
Gls Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 13862.30%
*******
*******
*******
*******
Revenue from Operations
*******
 13880.99%
*******
*******
*******
*******
Total Assets
*******
 18288.93%
*******
*******
*******
*******
Profit or Loss
*******
 8628.69%
*******
*******
*******
*******
Net Worth
*******
 22564.11%
*******
*******
*******
*******
EBITDA
*******
 12459.10%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gls Pharma?

In 2023, Gls Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹20,000,000.00

Satisfied Charges

₹158,300,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
20 Sep 2022 Canara Bank ₹2.00 Cr Open
30 Aug 2021 Canara Bank ₹2.50 Cr Satisfied
15 Dec 2020 Syndicate Bank ₹9.60 M Satisfied
14 Dec 2020 Canara Bank ₹8.00 M Satisfied
30 Sep 2015 Syndicate Bank ₹7.97 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Gls Pharma?

Gls Pharma has a workforce of 116 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gls Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gls Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gls Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Pendem Harish Babu was appointed as a Additional Director was appointed as a Additional Director on 25 Oct 2025 & has been associated with this company since 3 months 18 days . was completed.

  • Annual General Meeting

    The activity Gls Pharma Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge with Canara Bank of Rs. 2.00 Cr registered on 20 Sep 2022 with Charge ID 100616943 was modified on 18 Jun 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Gls Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    The activity A charge registered on 11 Jan 2007 via Charge ID 10033531 with Icici Bank Limited was fully satisfied on 20 Jan 2025. was completed.

  • Director Appointment

    The activity Ravikiran Namburi was appointed as a Director was appointed as a Director on 20 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gls Pharma Limited?

The CIN of Gls Pharma Limited is U24239TS2004PLC184306.

Where is Gls Pharma Limited headquartered?

Gls Pharma Limited is headquartered at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1,, Hyderabad Knowledge City, Raidurg Panmaktha,, Seri Lingampally, Telangana, 500032.

When was Gls Pharma Limited incorporated?

Gls Pharma Limited was incorporated on 01 September 2004.

Who are the current directors of Gls Pharma Limited?

The current directors of Gls Pharma Limited are

What is the primary industry of Gls Pharma Limited?

The primary industry of Gls Pharma Limited is Manufacturing.

Is Gls Pharma Limited a listed company?

Gls Pharma Limited is unlisted.

What is the capital structure of Gls Pharma Limited?

The authorized capital of Gls Pharma Limited is ₹1.30 Cr, and the paid-up capital is ₹1.20 Cr.

What is the compliance status of Gls Pharma Limited?

The compliance status of Gls Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available